Market Research Logo

Advanced Wound Management - Medical Devices Pipeline Assessment, 2016

Advanced Wound Management - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Advanced Wound Management - Medical Devices Pipeline Assessment, 2016 provides an overview of Advanced Wound Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Advanced Wound Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Advanced Wound Management under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Advanced Wound Management and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Advanced Wound Management under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Advanced Wound Management Overview
3 Products under Development
3.1 Advanced Wound Management - Pipeline Products by Stage of Development
3.2 Advanced Wound Management - Pipeline Products by Segment
3.3 Advanced Wound Management - Pipeline Products by Territory
3.4 Advanced Wound Management - Pipeline Products by Regulatory Path
3.5 Advanced Wound Management - Pipeline Products by Estimated Approval Date
3.6 Advanced Wound Management - Ongoing Clinical Trials
4 Advanced Wound Management - Pipeline Products under Development by Companies
4.1 Advanced Wound Management Companies - Pipeline Products by Stage of Development
4.2 Advanced Wound Management - Pipeline Products by Stage of Development
5 Advanced Wound Management Companies and Product Overview
5.1 3QMatrix, Inc. Company Overview
5.2 3S BioMedical, Inc. Company Overview
5.3 Abeona Therapeutics Inc Company Overview
5.4 Acelity L.P. Inc. Company Overview
5.5 Advanced Medical Solutions Group plc Company Overview
5.6 Advanced Plasma Products, Inc. Company Overview
5.7 AGAM Biological Products Company Overview
5.8 Agenta Biotechnologies Inc Company Overview
5.9 Akeso Biomedical, Inc. Company Overview
5.10 Alafair Biosciences Inc Company Overview
5.11 Alliance Pharma Inc Company Overview
5.12 Alliqua BioMedical Inc Company Overview
5.13 Amarantus Bioscience Holdings Inc Company Overview
5.14 AnGes MG Inc Company Overview
5.15 Angiotech Pharmaceuticals Inc Company Overview
5.16 Anika Therapeutics Inc Company Overview
5.17 ApoPharma Inc Company Overview
5.18 ARC Medical Devices Inc. Company Overview
5.19 Aroa Biosurgery Ltd Company Overview
5.20 Arsenal Medical Inc Company Overview
5.21 Arteriocyte Medical Systems Inc Company Overview
5.22 Asana Medical, Inc. Company Overview
5.23 Aspen Surgical Products Company Overview
5.24 Avita Medical Ltd Company Overview
5.25 Axcelon Biopolymers Corp. Company Overview
5.26 Baxter International Inc Company Overview
5.27 Bayer HealthCare AG Company Overview
5.28 BioCure, Inc. Company Overview
5.29 Biomendics, LLC Company Overview
5.30 BioPhotas, Inc. Company Overview
5.31 BioRegenerative Sciences, Inc. Company Overview
5.32 BioSurfaces, Inc. Company Overview
5.33 Biotec Pharmacon ASA Company Overview
5.34 BioTime Inc Company Overview
5.35 Biovation LLC Company Overview
5.36 botiss dental GmbH Company Overview
5.37 Brigham and Women's Hospital Company Overview
5.38 Camurus AB Company Overview
5.39 CelaCare Technologies, Inc. Company Overview
5.40 CellTran Limited (Inactive) Company Overview
5.41 Ceramicos Para Aplicacoes Medicas Lda Company Overview
5.42 Chi2Gel Ltd. Company Overview
5.43 Clearbridge Accelerator Pte Ltd Company Overview
5.44 CMB Science Inc. Company Overview
5.45 Coloplast A/S Company Overview
5.46 Coltrix Biomedical Company Overview
5.47 Consejo Superior de Investigaciones Cientificas Company Overview
5.48 Conversion Energy Enterprises Company Overview
5.49 Corium International Inc Company Overview
5.50 CorMedix Inc Company Overview
5.51 Covalon Technologies Ltd Company Overview
5.52 DeCell Technologies Inc Company Overview
5.53 Dipromed Srl Company Overview
5.54 Divya Laboratories Company Overview
5.55 Drexel University Company Overview
5.56 Dynamic Techno Medicals Company Overview
5.57 Edixomed Ltd Company Overview
5.58 EnzySurge Ltd Company Overview
5.59 Eqalix Inc Company Overview
5.60 E-QURE Corp. Company Overview
5.61 EternoGen, LLC Company Overview
5.62 European Medical Contract Manufacturing B.V. Company Overview
5.63 Factor Therapeutics Ltd Company Overview
5.64 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview
5.65 FzioMed Inc Company Overview
5.66 Genewel Co Ltd Company Overview
5.67 Genzyme Corp Company Overview
5.68 Giltech Ltd Company Overview
5.69 Harbor MedTech, Inc. Company Overview
5.70 Healagenics, Inc. Company Overview
5.71 Hemostasis, LLC Company Overview
5.72 Histocell SL Company Overview
5.73 Holista CollTech Ltd Company Overview
5.74 HyperBranch Medical Technology, Inc. Company Overview
5.75 Ilika plc Company Overview
5.76 Imbed Biosciences, Inc. Company Overview
5.77 Indian Institute of Technology, Kanpur Company Overview
5.78 Innocoll Technologies Ltd Company Overview
5.79 Integra LifeSciences Corp Company Overview
5.80 InVivo Therapeutics Corporation Company Overview
5.81 IPI Singapore Company Overview
5.82 Jellagen Pty Ltd Company Overview
5.83 John Hopkins University Company Overview
5.84 KeraCure, Inc. (Inactive) Company Overview
5.85 KeraNetics, LLC Company Overview
5.86 Khorionyx Company Overview
5.87 Klox Technologies Inc Company Overview
5.88 Kyeron BV Company Overview
5.89 Lattice Biologics Ltd Company Overview
5.90 Leiden University Company Overview
5.91 Luna Innovations Inc Company Overview
5.92 Magen OrthoMed Ltd Company Overview
5.93 Magenta Medical Inc Company Overview
5.94 Maxigen Biotech Inc Company Overview
5.95 Medtric Biotech, LLC Company Overview
5.96 Medtronic plc Company Overview
5.97 Menodys Inc. Company Overview
5.98 MiMedx Group Inc Company Overview
5.99 MxBiodevices, LLC. Company Overview
5.100 Nanotherapeutics Inc Company Overview
5.101 NanoVibronix Inc Company Overview
5.102 National Cheng-Kung University Hospital Company Overview
5.103 Neotherix Ltd Company Overview
5.104 Newcastle University Company Overview
5.105 NitricGen, Inc. Company Overview
5.106 Northwestern University Company Overview
5.107 NovaBay Pharmaceuticals Inc Company Overview
5.108 NovelMed Therapeutics Inc Company Overview
5.109 Novyx Technologies LLC Company Overview
5.110 Nuvo Pharmaceuticals Inc Company Overview
5.111 Old Dominion University Company Overview
5.112 Oxtex Ltd Company Overview
5.113 OxyBand Technologies Inc Company Overview
5.114 Pathfinder Cell Therapy Inc Company Overview
5.115 Perfuzia Medical, Inc. Company Overview
5.116 Pernix Therapeutics Holdings Inc Company Overview
5.117 Pharmagenix AG Company Overview
5.118 Piramal Enterprises Ltd Company Overview
5.119 PlasMedica Technologies Limited Company Overview
5.120 Plurogen Therapeutics Inc Company Overview
5.121 PolyActiva Pty Ltd Company Overview
5.122 PolyNovo Biomaterials Pty Ltd Company Overview
5.123 Protein Polymer Technologies Inc (Inactive) Company Overview
5.124 Q Care Medical Services BVBA Company Overview
5.125 Quick-Med Technologies, Inc. Company Overview
5.126 RenovaCare, Inc. Company Overview
5.127 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.128 Rimon Therapeutics Ltd Company Overview
5.129 Rutgers The State University of New Jersey Company Overview
5.130 SANUWAVE Health Inc Company Overview
5.131 Sarasota Medical Products Inc Company Overview
5.132 Shire Plc Company Overview
5.133 Siemens Healthcare GmbH Company Overview
5.134 Sinclair Pharma PLC Company Overview
5.135 Sintact Medical Systems, LLC Company Overview
5.136 SIRIM Berhad Company Overview
5.137 Smith & Nephew Plc Company Overview
5.138 STB Lifesaving Technologies Company Overview
5.139 Stratatech Corp Company Overview
5.140 Stratpharma AG Company Overview
5.141 Taxus Cardium Pharmaceuticals Group Inc Company Overview
5.142 Tel Aviv Sourasky Medical Center Company Overview
5.143 Tel Aviv University Company Overview
5.144 Tenax Therapeutics Inc Company Overview
5.145 The Chinese University of Hong Kong Company Overview
5.146 The University of Queensland Company Overview
5.147 Tissue Regenix Ltd Company Overview
5.148 Trans-Technologies Ltd Company Overview
5.149 Trinity College Dublin Company Overview
5.150 ULURU Inc Company Overview
5.151 Universitat Politecnica de Catalunya Company Overview
5.152 Universite De Lyon Company Overview
5.153 University of Akron Company Overview
5.154 University of Bath Company Overview
5.155 University of California San Diego Company Overview
5.156 University of Florida Company Overview
5.157 University of Glasgow Company Overview
5.158 University of South Florida Company Overview
5.159 University of Texas at Arlington Company Overview
5.160 University of Washington Company Overview
5.161 University of Wisconsin Madison Company Overview
5.162 Vancive Medical Technologies Company Overview
5.163 Vascular Solutions, Inc. Company Overview
5.164 Ventrix Inc Company Overview
5.165 Worcester Polytechnic Institute Company Overview
5.166 Zeomedix, LLC Company Overview
5.167 ZetrOZ, Inc. Company Overview
6 Advanced Wound Management- Recent Developments
6.1 Nov 30, 2016: Graham Baker appointed Chief Financial Officer
6.2 Nov 29, 2016: NIH Funds Clinical Trial To Test Device That Heals Wounds With Ultrasound
6.3 Nov 28, 2016: Misonix Reports Nasdaq's Acceptance of Its Plan to Regain Listing Compliance
6.4 Nov 22, 2016: Peer-reviewed Publication on the use of Grafix in High-Risk Peripheral Arterial Disease Patients with Treatment Refractory Ulcerations Demonstrating Durable Wound Closure
6.5 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.6 Nov 22, 2016: Innocoll Announces Third Quarter 2016 Financial and Operating Results and Provides Corporate Update
6.7 Nov 22, 2016: Pernix appoints new board member
6.8 Nov 22, 2016: Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass.
6.9 Nov 21, 2016: Osiris Provides Update Regarding NASDAQ Listing Matters
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Lung Cancer
Table 2: Histological Subtype Distribution Among NSCLC
Table 3: 8MM, Relative Survival
Table 4: 8MM, Sources Used for Diagnosed Incidence of NSCLC
Table 5: 8MM, Sources Used for Cancer Stage at Diagnosis
Table 6: 8MM, Sources Used for NSCLC by Histological Subtypes
Table 7: US, Sources Used for Diagnosed Incident Cases of NSCLC Segmented by Mutation
Table 8: 5EU, Sources Used for Diagnosed Incident Cases of NSCLC Segmented by Mutation
Table 9: Japan, Sources Used for Diagnosed Incident Cases of NSCLC Segmented by Mutation
Table 10: China (Urban), Sources Used for Diagnosed Incident Cases of NSCLC Segmented by Mutation
Table 11: 8MM, Sources Used for Relative Survival of NSCLC
Table 12: 8MM, Diagnosed Incident Cases of NSCLC, Both Sexes, Ages ≥18 Years, N, Select Years 2015-2025
Table 13: 8MM, Age-Specific Diagnosed Incident Cases of NSCLC, Both Sexes, N (Row %), 2015
Table 14: 8MM, Sex-Specific Diagnosed Incident Cases of NSCLC, Ages ≥18 Years, N (Row %), 2015
Table 15: 8MM, Diagnosed Incident Cases of NSCLC by Clinical Stage at Diagnosis, Ages ≥18 Years, N, 2015
Table 16: 8MM, Diagnosed Incident Cases of NSCLC by Histological Subtypes, Ages ≥18 Years, N, 2015
Table 17: 8MM, Mutations Among Diagnosed Incident Cases of Adenocarcinoma, Both Sexes, Ages ≥18 Years, N, 2015
Table 18: 8MM, Mutations Among Diagnosed Incident Cases of Squamous Cell Carcinoma, Both Sexes, Ages ≥18 Years, N, 2015
Table 19: 8MM, Mutations Among Diagnosed Incident Cases of NSCLC, Both Sexes, N, Ages ≥18 Years, 2015
Table 20: 8MM, Five-Year Diagnosed Prevalent Cases of NSCLC, Both Sexes, Ages ≥18 Years, N, Select Years 2015-2025
Table 21: 8MM, Alternate Forecast, Diagnosed Incident Cases of NSCLC by Histology Subtypes, Ages ≥18 Years, N, 2015 and 2025
Table 22: 8MM, Alternate Forecast, Five-Year Diagnosed Prevalent Cases of NSCLC, Both Sexes, Ages ≥18 Years, N, Select Years 2015-2025
1.2 List of Figures
Figure 1: Advanced Wound Management - Pipeline Products by Stage of Development
Figure 2: Advanced Wound Management - Pipeline Products by Segment
Figure 3: Advanced Wound Management - Pipeline Products by Territory
Figure 4: Advanced Wound Management - Pipeline Products by Regulatory Path
Figure 5: Advanced Wound Management - Pipeline Products by Estimated Approval Date
Figure 6: Advanced Wound Management - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report